ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Smoking Nears Goals With “New Generation”

January 9, 1976

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

Obama Signs Spending Bill for FY09

March 13, 2009

AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows

August 28, 2009

NCI Community Cancer Centers RFP Issued; Advisors Criticize Project Structure.

November 10, 2006